The world is experiencing an unprecedented health crisis as a result of the highly infectious novel coronavirus. Even economically powerful countries with the best healthcare and technology infrastructure are struggling to contain COVID-19. Conventional medicine is racing against time to produce vaccine and repurpose drugs used in other viral diseases. India has been using its resources maximally to fight COVID-19. However, it is yet to make full use of one of its major resource, namely AYUSH (Ayurveda, Yoga, Unaani, Siddha and Homeopathy) systems. Ayurveda, which occupies a prime position in the AYUSH systems, has a huge knowledge base and infrastructure accessible in terms of registered practitioners, dispensaries, colleges, hospitals, pharmacies, research centres, etc. It is hence only logical that in a crisis like COVID -19, ayurveda is utilised for the public. Considering the vast clinical knowledge and experience available with ayurveda, this sector should definitely be an advantage for India. This article will discuss why and how the knowledge base and support system of ayurveda sector should be leveraged in trying times as the present one.

中文翻译：

---

阿育吠陀可用于COVID-19吗？

由于高度感染性的新型冠状病毒，世界正面临着前所未有的健康危机。即使是拥有最佳医疗保健和技术基础设施的经济强国，也都在努力遏制COVID-19。常规药物正在争分夺秒地生产用于其他病毒性疾病的疫苗和再利用药物。印度一直在最大限度地利用其资源来对抗COVID-19。但是，它尚未充分利用其主要资源之一，即AYUSH（阿育吠陀，瑜伽，乌纳尼，悉达和顺势疗法）系统。阿育吠陀在AYUSH系统中占据主要地位，拥有庞大的知识库和基础架构，可从注册从业人员，药房，学院，医院，药房，研究中心等获取。 -19，阿育吠陀用于公众。考虑到阿育吠陀提供的大量临床知识和经验，该领域绝对是印度的优势。本文将讨论为什么以及如何在目前的尝试时期利用阿育吠陀领域的知识库和支持系统。